Emetine

Emetine

SCHEMBL14029342

CCC1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 7/20 1.00
MEN1 O00255 6/20 1.00
KMT2A Q03164 6/20 1.00
SMN1; SMN2 Q16637 5/20 1.00
SLC2A1 P11166 5/20 1.00
LMNA P02545 4/20 1.00
CYP3A4 P08684 3/20 1.00
MAPK1 P28482 3/20 1.00
NPC1 O15118 3/20 1.00
RAB9A P51151 3/20 1.00
EPAS1 Q99814 3/20 1.00
MAPT P10636 2/20 1.00
STAT6 P42226 2/20 1.00
TP53 P04637 1/20 1.00
NFKB1 P19838 1/20 1.00
THPO P40225 1/20 1.00
HTT P42858 1/20 1.00
RBBP9 O75884 1/20 1.00
ABCB1 P08183 1/20 1.00
HTR1A P08908 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Emetine SCHEMBL14135123 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL29392786 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL14261157 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL29390500 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL13226748 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL14269958 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL24499457 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL56277 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL13912579 1.00 HIF1A (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1
Emetine SCHEMBL2382448 0.99 MEN1 (1.00) HIF1AMEN1KMT2ASMN1; SMN2SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080267948-A1 Croos-B Structure Binding Compounds CROSSBETA BIOSCIENCES B.V. (NL) 2008-10-30 US disclosed
US-20080267948-A1 Croos-B Structure Binding Compounds CROSSBETA BIOSCIENCES B.V. (NL) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080267948-A1 Croos-B Structure Binding Compounds CACYBP, TBCB, MYCBP HIF1A 2809/4885MEN1 4546/4885KMT2A 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.